A novel approach for asymmetric synthesis of both enantiomeric aldol products has been developed by designing two different chiral organocatalysts from a readily available, protected cis-diamine compound as a common chiral source. This approach would be very useful from a practical viewpoint.
No takes yet. Share an insight, caveat, or question.
Nakayama et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: